A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis
Version of Record online: 23 DEC 2012
© 2012 Blackwell Publishing Ltd
Neurogastroenterology & Motility
Volume 25, Issue 2, pages e140–e150, February 2013
How to Cite
Ejskjaer, N., Wo, J. M., Esfandyari, T., Mazen Jamal, M., Dimcevski, G., Tarnow, L., Malik, R. A., Hellström, P. M., Mondou, E., Quinn, J., Rousseau, F. and McCallum, R. W. (2013), A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesis. Neurogastroenterology & Motility, 25: e140–e150. doi: 10.1111/nmo.12064
- Issue online: 22 JAN 2013
- Version of Record online: 23 DEC 2012
- Received: 1 August 2012 Accepted for publication: 19 November 2012
Figure S1. Linear regression of gastric T½ vs absolute blood glucose.
|NMO_12064_sm_FigureS1.jpg||180K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.